These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4203575)

  • 1. Molindone: a crossover evaluation of capsule and tablet formulations in severely ill schizophrenic patients.
    Gallant DM; Bishop MP; Steele CA; Bishop G; Guerrero-Figueroa R
    Curr Ther Res Clin Exp; 1973 Dec; 15(12):915-8. PubMed ID: 4203575
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the clinical and electroencephalographical effects of molindone and trifluoperazine in acute schizophrenic patients.
    Itil TM; Polvan N; Ucok A; Eper E; Güven F; Hsu W
    Behav Neuropsychiatry; 1971 Dec; 3(9):6-13. PubMed ID: 4948869
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of molindone and placebo in anxious depressed patients.
    Goldstein BJ; Brauzer B
    Curr Ther Res Clin Exp; 1971 Jun; 13(6):344-9. PubMed ID: 4397132
    [No Abstract]   [Full Text] [Related]  

  • 4. A double-blind comparison of molindone and trifluoperazine in the treatment of acute schizophrenia.
    Simpson GM; Amin M; Edwards JG
    J Clin Pharmacol New Drugs; 1971; 11(3):227-36. PubMed ID: 4946101
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of trifluoperazine and molindone in chronic schizophrenic patients.
    Freeman H; Frederick AN
    Curr Ther Res Clin Exp; 1969 Nov; 11(11):670-6. PubMed ID: 4982301
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of the clinical and electroencephalographical effects of molindone and trifluoperazine in acute schizophrenic patients.
    Itil TM; Polvan N; Ucok A; Eper E; Güven F; Hsu W
    Behav Neuropsychiatry; 1971; 3(5):25-32. PubMed ID: 4948596
    [No Abstract]   [Full Text] [Related]  

  • 7. Milipertine: an early evaluation in severely ill schizophrenics.
    Mielke DH; Gallant DM; Bishop MP
    Curr Ther Res Clin Exp; 1973 Jun; 15(6):324-6. PubMed ID: 4197256
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical evaluation of a new psychotropic drug--molindone.
    Ramsay RA; Lehmann HE; Ban TA; Saxena BM; Bennett J
    Int Z Klin Pharmakol Ther Toxikol; 1970 Jan; 3(1):46-8. PubMed ID: 4909378
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of loxapine hydrochloride oral concentrate (loxitane C) in acute schizophrenia.
    Wittkopp TA
    J Clin Psychiatry; 1978 Feb; 39(2):154-7. PubMed ID: 344304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of acute schizophrenia with molindone.
    Abuzzahab FS
    J Clin Pharmacol; 1973; 13(5):226-33. PubMed ID: 4575563
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparative study of parenteral molindone and haloperidol in the acutely psychotic patient.
    Binder R; Glick I; Rice M
    J Clin Psychiatry; 1981 May; 42(5):203-6. PubMed ID: 7217025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A clinical comparison of molindone hydrochloride with trifluoperazine in psychotic outpatients.
    Brauzer B; Goldstein BJ
    Curr Ther Res Clin Exp; 1971 Mar; 13(3):152-7. PubMed ID: 4998285
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term study of molindone hydrochloride in chronic schizophrenics.
    Kellner R; Rada RT; Egelman A; Macaluso B
    Curr Ther Res Clin Exp; 1976 Nov; 20(5):686-94. PubMed ID: 825355
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term use of molindone in schizophrenics.
    Abuzzahab FS
    J Clin Pharmacol; 1973 Oct; 13(10):422-6. PubMed ID: 4583573
    [No Abstract]   [Full Text] [Related]  

  • 15. Differential effects of trazodone in depressed, schizophrenic and geriatric patients.
    Ban TA; Lehmann HE; Amin M; Bronheim LA; Klingner A; Nair NP; Galvan L; Vergara L; Zoch C
    Int J Clin Pharmacol; 1974 Jan; 9(1):23-7. PubMed ID: 4593127
    [No Abstract]   [Full Text] [Related]  

  • 16. Trazodone in the treatment of schizophrenias.
    Galvan L; Nair NP; Kussin D; Ban TA
    Curr Ther Res Clin Exp; 1973 Oct; 15(10):776-80. PubMed ID: 4201975
    [No Abstract]   [Full Text] [Related]  

  • 17. Molindone: a controlled evaluation in chronic schizophrenic patients.
    Gallant DM; Bishop MP
    Curr Ther Res Clin Exp; 1968 Sep; 10(9):441-7. PubMed ID: 4971648
    [No Abstract]   [Full Text] [Related]  

  • 18. Rapidly disintegrating risperidone in subjects with schizophrenia or schizoaffective disorder: a summary of ten phase I clinical trials assessing taste, tablet disintegration time, bioequivalence, and tolerability.
    Thyssen A; Remmerie B; D'Hoore P; Kushner S; Mannaert E
    Clin Ther; 2007 Feb; 29(2):290-304. PubMed ID: 17472821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic thyroid releasing hormone (TRH) administered orally to chronic schizophrenic patients.
    Clark ML; Paredes A; Costiloe JP; Wood F
    Psychopharmacol Commun; 1975; 1(2):191-200. PubMed ID: 817373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical evaluation of the efficacy of molindone and chlordiazepoxide in anxious outpatients.
    Carranza-Acevedo J; Tovar-Acosta H
    Curr Ther Res Clin Exp; 1972 Sep; 14(9):609-14. PubMed ID: 4628683
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.